| 13.32 -0.6 (-4.31%) | 03-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 18.87  |
1-year : | 20.99 |
| Resists | First : | 16.16 |
Second : | 17.97 |
| Pivot price | 15.56 |
|||
| Supports | First : | 13.22 |
Second : | 11 |
| MAs | MA(5) : | 14.1 |
MA(20) : | 15.97 |
| MA(100) : | 17.02 |
MA(250) : | 14.64  |
|
| MACD | MACD : | -1.1 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 1.1 |
D(3) : | 3.3 |
| RSI | RSI(14): 14.8 |
|||
| 52-week | High : | 19.85 | Low : | 9.52 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SHC ] has closed above bottom band by 4.2%. Bollinger Bands are 155.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 13.94 - 14.07 | 14.07 - 14.16 |
| Low: | 12.95 - 13.12 | 13.12 - 13.22 |
| Close: | 13.12 - 13.4 | 13.4 - 13.57 |
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Wed, 11 Mar 2026
Sotera Health Board Member Trades $229.05M In Company Stock - Benzinga
Wed, 11 Mar 2026
Insider Transaction: WARBURG PINCUS CO Sells $229.05M Worth Of Sotera Health Shares - Benzinga
Mon, 09 Mar 2026
Is Sotera Health (SHC) Attractively Priced After Recent Share Price Pullback? - Yahoo Finance
Sat, 07 Mar 2026
Sotera Health Ownership Shift As 25m Share Sale Tests Valuation - Sahm
Fri, 06 Mar 2026
Sotera Health stockholders sell 25 million shares in secondary offering - Investing.com
Thu, 05 Mar 2026
Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 284 (M) |
| Shares Float | 154 (M) |
| Held by Insiders | 2.4 (%) |
| Held by Institutions | 94.3 (%) |
| Shares Short | 7,670 (K) |
| Shares Short P.Month | 6,400 (K) |
| EPS | 0.27 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.13 |
| Profit Margin | 6.6 % |
| Operating Margin | 35.7 % |
| Return on Assets (ttm) | 8.1 % |
| Return on Equity (ttm) | 15.4 % |
| Qtrly Rev. Growth | 4.5 % |
| Gross Profit (p.s.) | 2.26 |
| Sales Per Share | 4.07 |
| EBITDA (p.s.) | 1.94 |
| Qtrly Earnings Growth | 175.3 % |
| Operating Cash Flow | 287 (M) |
| Levered Free Cash Flow | 237 (M) |
| PE Ratio | 49.33 |
| PEG Ratio | 0 |
| Price to Book value | 6.25 |
| Price to Sales | 3.26 |
| Price to Cash Flow | 13.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|